J-GLOBAL ID:200901094372694281   Update date: Nov. 29, 2005

Ishii Yuji

イシイ ユウジ | Ishii Yuji
Affiliation and department:
Job title: Assitance Professor
Research field  (2): Digestive surgery ,  General surgery, pediatric surgery
Research keywords  (5): Liver transplantation ,  Hepatocellular carcinoma ,  Angiogenesis ,  Artficial liver ,  Regenerative medicine
Research theme for competitive and other funds  (4):
  • 2002 - 2007 The Possibility of the Clinical Application Relevant to the Endogeneous Cannabinoids in Chronic liver disease
  • 2000 - 2004 A study on a bioartificial liver and reconstruction of liver by means of radial flow bioreactor
  • 1998 - 2003 Combination antiangigenic treatment on primary hepatocellular carcinoma
  • Regenerative Medicine of Liver
MISC (27):
  • Yuji Ishii, Tokuyasu Yokota, Hideki Kanai, Hideki Marushima, Yoji Yamazaki and Kastuhiko Yanaga. The Role of Endogenous Cannabinoids for Patients with Hepatocellular Carcinoma Secondary to Chronic Liver Disease. The 6TH World Congress of the International Hepato-Pancreato-Biliary Association. 2004
  • Yuji Ishii, Hideki Kanai, Hideki Marushima, Tokuyasu Yokota, Tomokazu Matsuura, Susumu Kobayashi, Yoji Yamazaki and Kastuhiko Yanaga. Oral presentation Hybrid Artificial Liver and Reconstruction of Mini-Liver from Porcine Fetal Using Radial-Flow Biorea・・・. The 6TH World Congress of the International Hepato-Pancreato-Biliary Association. 2004
  • Ishii Y, Nakaato Y, Kobayahi S, Yamazaki Y, Aoki T., A Study on Angiogenesis-Related Matrix Metalloproteinase Network in Primary Hepatocellular Carcinoma. J.Exp.Clin. Cancer. Res. 2003. 22(3) 461-470
  • Y. Ishii, Y. Nakasato, S. Kobayashi, Y. Yamazaki, Y. Inagaki, WHAT IS AN EFFECTIVE ANTI-ANGIOGENIC TREATMENT AGAINST HEPATOCELLULAR CARCINOMA? - MATRIX METALLOPROTEINASE INHIBITOR SENSITIVITY -. American College of Gastroenterlogy 67th Annual Scientific Meeting(Seattle USA). 2002
  • Y. Ishii, Y. Nakasato, S. Yanagisawa, S. Kobayashi, Y. Yamazaki, T. Aoki, Strategy for the clinical application of antiangiogenic treatment againsyt hepatocellular carcinoma-Mainly focused on matrix metalloproteinase and HCV. 5th WORLD CONGRESS OF THE INTRERNATIONAL HEPATO-PANCREATO-BILIALY ASSOCIATION. 2002
Works (1):
  • Development of an artificial liver and application by means of radial flow bioreactor
    1999 - 2002
Education (3):
  • - 1988 Jikei University Graduate School, Division of Medicine Sirgery
  • - 1984 Jikei University Faculty of Medicine
  • - 1984 Jikei University Faculty of Medicine Medicine
Professional career (1):
  • Doctor(Medicine) (Jikei University)
Work history (10):
  • 1998 - 2006 Instructor in Surgery (Jikei)
  • 1997 - 2006 Jikei University
  • 1994 - 1997 Medical Staff in Surgery(Jikei)
  • 1994 - 1996 Jikei University
  • 1992 - 1993 Nebraska Medical Center Transplantation unit.
Show all
Association Membership(s) (5):
The Japanese Society of Transplantation ,  The Japanese Association of Hepato-Biliary-Pancreatic Surgery ,  The Japanese Society of Gastroentelogy ,  The Japanese Society of Gastroentelogical Surgery ,  Japan Surgical Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page